title: Evaluation of current therapeutic strategies in Behçet's disease.
abstract: Behçet's disease (BD) is a chronic relapsing vasculitis with multifunctional pathogenesis. The mucocutaneous and ocular lesions are the commonest manifestations, but BD also affects the musculoskeletal, intestinal, cardiac, and central nervous system. BD therapy is based on the suppression of the inflammatory process, using immunomodulating and immunosuppressive agents. In selected cases, invasive procedures may be required.
authors.affiliation: First Department of Internal Medicine, University of Athens, Laikon Hospital, 69 Vosporou Str, Athens, 10444, Greece. aleiliana@yahoo.gr
authors.forename: Iliana
authors.initials: I
authors.lastname: Alexoudi
authors.forename: Violetta
authors.initials: V
authors.lastname: Kapsimali
authors.forename: Aristides
authors.initials: A
authors.lastname: Vaiopoulos
authors.forename: Meletios
authors.initials: M
authors.lastname: Kanakis
authors.forename: George
authors.initials: G
authors.lastname: Vaiopoulos
mesh_terms: D001528:Behcet Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D056747:Immunomodulation; D007166:Immunosuppressive Agents / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents